Diagnosis

Rare disease diagnosis is usually a complex and lengthy journey, filled with challenges for patients and healthcare providers alike. From identifying symptoms to accessing specialized testing, understanding the process can bring clarity and hope. This page highlights the latest diagnostic tools, expert insights, and patient stories to shed light on this crucial step in rare disease care.

UCB Study Highlights the Burden of Ocular Myasthenia Gravis

UCB Study Highlights the Burden of Ocular Myasthenia Gravis

Anna Kole, Global Patient Engagement Lead for Myasthenia Gravis at UCB, discusses findings from a mixed-methods study examining the experiences and unmet needs of people living with ocular myasthenia gravis (oMG) and explains how patient perspectives could improve clinical research and care.

More

Ultragenyx Gets $203M in Second Priority Review Voucher This Month | The CheckRare Brief

On this episode, we discuss the FDA approval of Enspryng for TED, the new FDA Rare Disease Framework Initiative, Ultrangenyx’s second sold PRV this month, and using AI to reduce diagnostic delays....

Therapies for MCT8 Deficiency and Nephrotic Syndrome Get FDA Approval | The CheckRare Brief Ep 10

On September 28th, the FDA approved Emcitate, or tiratricol, from Egetis Therapeutics. It's the first-ever treatment for MCT8 deficiency, a condition also known as Allan-Herndon-Dudley syndrome. ...

First-Line Therapy Approved for Rare Lung Cancer | The CheckRare Brief Ep 7

  This week, three developments highlight the rapidly changing rare disease treatment landscape: a Phase 3 setback in Angelman syndrome, continued competition in hereditary angioedema, and an...

New Huntington’s Disease Gene Therapy Application | The CheckRare Brief Ep 6

  In this episode of The CheckRare Brief, we discuss two recent FDA approvals for rare diseases, including Zanvastro for Alexander disease and Besremi for essential thrombocythemia (ET). We...

Getting a Rare Disease Drug Approved Is Only Half the Battle | The CheckRare Brief Ep 4

  FDA approval is a major milestone, but for patients with rare diseases, it is only the beginning. In this episode of The CheckRare Brief, we look at two new rare disease approvals, ongoing...

FDA Approves New Narcolepsy Treatment | The CheckRare Brief

  On this week’s episode of The CheckRare Brief, we discuss FDA's approval of Orzeyful (oveporexton) to treat patients with narcolepsy type 1, CAMP4’s first-in-human clinical trial for patients...

FDA Advisory Board’s Concerns About New Duchenne Drug, Brain Fog in Immune Thrombocytopenia

The CheckRare Brief delivers a concise summary of the week's most important developments in rare diseases. Each episode covers FDA approvals, clinical trial updates, conference highlights,...

Recent Videos

Spinal Muscular Atrophy: The Changing Definition of Success

Spinal Muscular Atrophy: The Changing Definition of Success

Drs. Nancy Kuntz, Alicia Henriquez, and Angela Lek discuss how advances in therapies have changed the outlook for patients with SMA.